Voyager Therapeutics, Inc.
VYGR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001640266
No open-market purchases or sales by Voyager Therapeutics, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $122.7M in total; no superinvestor holds it.
Holders of 5% or more of VYGR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Voyager Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 13G/A | 8.65%4.80M shares | – | Aug 14, 20251 filing | Aug 14, 2025 | SEC |
| Integrated Core Strategies (US) LLC | 13G/A | 7.40%4.44M shares | +1.30 ppfrom 6.10% | Jan 26, 20262 filings | Jul 31, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 6.40%3.53M shares | – | Apr 24, 20251 filing | Apr 24, 2025 | SEC |
| Armistice Capital, LLC | 13G/A | 5.58%3.44M shares | −0.29 ppfrom 5.87% | Feb 16, 202111 filings | Aug 14, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
37 Schedule 13D and 13G filings on Voyager Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 202610:30 AM ET | Armistice Capital, LLCand 1 other | 13G/A | 5.58%3.44M shares | −0.29 ppfrom 5.87% | Jun 30, 2026 | SEC |
| Jul 31, 20266:15 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G/A | 7.40%4.44M shares | +1.30 ppfrom 6.10% | Jun 30, 2026 | SEC |
| May 15, 20262:16 PM ET | EcoR1 Capital, LLCand 2 others | 13G/A | 0.00%0 shares | −6.80 ppfrom 6.80%Below 5% | Mar 31, 2026 | SEC |
| May 15, 202611:04 AM ET | Armistice Capital, LLCand 1 other | 13G/A | 5.87%3.50M shares | −1.32 ppfrom 7.19% | Mar 31, 2026 | SEC |
| Mar 27, 20262:17 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Feb 18, 202611:15 AM ET | Armistice Capital, LLCand 1 other | 13G/A | 7.19%4.00M shares | −0.38 ppfrom 7.57% | Dec 31, 2025 | SEC |
| Feb 17, 20266:21 PM ET | EcoR1 Capital, LLCand 2 others | 13G/A | 6.80%4.00M shares | 0.00 ppfrom 6.80% | Dec 31, 2025 | SEC |
| Jan 26, 20264:05 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G | 6.10%3.41M shares | New | Jan 16, 2026 | SEC |
| Nov 14, 20256:30 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 7.57%4.20M shares | −2.28 ppfrom 9.85% | Sep 30, 2025 | SEC |
| Nov 14, 20253:47 PM ET | EcoR1 Capital, LLCand 2 others | 13G/A | 6.80%4.00M shares | – | Sep 30, 2025 | SEC |
| Aug 14, 20259:40 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 8.65%4.80M shares | – | Jun 30, 2025 | SEC |
| May 15, 20253:22 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.85%5.44M shares | −0.03 ppfrom 9.88% | Mar 31, 2025 | SEC |
| Apr 24, 20259:12 AM ET | BlackRock, Inc. | 13G/A | 6.40%3.53M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 20255:24 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.88%5.40M shares | – | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Aug 7, 20244:10 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Third Rock Ventures III, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 29, 20245:25 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 24, 20236:15 AM ET | Neurocrine Biosciences Inc | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Third Rock Ventures III, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Armistice Capital, LLC | 13GOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 13, 2023 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Apr 26, 2022 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 15, 2022 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | BB Biotech AG | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Oct 22, 2021 | EcoR1 Capital, LLC | 13GOld format | – | New | – | SEC |
| Jul 12, 20218:29 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | BB Biotech AG | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 1, 20218:30 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Voyager Therapeutics, Inc. shares.
No Form 144 notices for Voyager Therapeutics, Inc. are on file.